Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 3 of 3 citing Mima: Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion.... (0.15 sec) 

Smad1 as a Biomarker for Diabetic Nephropathy

- diabetesjournals.org
H Kato, H Si, T Hostetter, K Susztak - Diabetes, 2008 - Am Diabetes Assoc
Diabetic nephropathy is one of the most devastating complications of diabetes and develops
in about one-third of diabetic patients. Exposure to a hyperglycemic environment with coexisting
obesity, metabolic syndrome, hyperfiltration, hypertension, and hyperlipidemia plays a ...
Related articles - All 3 versions

The current clinical problems for early phase of diabetic nephropathy and …


T Doi, A Mima, T Matsubara, T Tominaga, H Arai, H … - Diabetes Research and …, 2008 - Elsevier
The important clinical problems of diabetic nephropathy are both proteinuria and decrease of
renal function. Pathological analysis showed decrease of GFR was correlated to degree of mesangial
expansion but not thickening of GBM nor the other findings in human type 1 diabetic ...
Related articles - All 8 versions

Therapeutic Strategies in the Treatment of Diabetic Nephropathy-a Translational …


IM Shah, SP Mackay, GA McKay - Current medicinal chemistry, 2009 - ingentaconnect.com
1 Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde,
Glasgow, Scotland, G4 0NR, UK 2 University Medical Unit, Glasgow Royal Infirmary, Castle
Street, Glasgow, Scotland, G4 0SF, UK Abstract: Type 2 Diabetes (T2D) is an important ...
Related articles - All 3 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google